Medicine and Dentistry
Tumor Angiogenesis
100%
Glioblastoma
100%
microRNA
100%
Circulating microRNA
66%
Temozolomide
26%
Endothelial Cell
26%
Angiogenesis
20%
Ganglioglioma
13%
Chemotherapy
6%
Lifespan
6%
Gene Expression
6%
Diseases
6%
Small Untranslated RNA
6%
Secretion (Process)
6%
Combination Therapy
6%
Cell Communication
6%
Metastatic Carcinoma
6%
Therapy Effect
6%
Biological Marker
6%
Bevacizumab
6%
Gene Control
6%
Antiinfective Agent
6%
Intracranial Tumor
6%
Blood Brain Barrier
6%
Xenograft
6%
Drug Resistance
6%
Survival Rate
6%
Cilengitide
6%
Growth Factor
6%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Glioblastoma
100%
Neoplasm
100%
Circulating microRNA
66%
Temozolomide
26%
Glioma
6%
Cilengitide
6%
Antiinfective Agent
6%
Small Untranslated RNA
6%
Drug Development
6%
Bevacizumab
6%
Therapeutic Effect
6%
Biological Marker
6%
Growth Factor
6%
Survival Rate
6%
Combination Therapy
6%
Drug Resistance
6%
Intracranial Tumor
6%
Blood-Brain Barrier
6%
Diseases
6%
Neuroscience
Circulating microRNA
100%
Angiogenesis
100%
MicroRNA
100%
Temozolomide
40%
Chemotherapy
20%
Gene Expression
10%
Gene Control
10%
Growth Factor
10%
Intracranial Tumor
10%
Small Untranslated RNA
10%
Drug Resistance
10%
Bevacizumab
10%
Blood Brain Barrier
10%
Cell Communication
10%
Glioblastoma Multiforme
10%
Cilengitide
10%